NCT05815160
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05815160
Title Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Debiopharm International SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Hospital Universitario de A Coruna A Coruña 15006 Spain Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
Institut Catala D'Oncologia - Badalona Barcelona 08908 Spain Details
Clinica Universidad de Navarra Madrid 28027 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario HM Sanchinarro. START Madrid - Centro Integral Oncológico Clara Campal (CIOCC) Madrid 28050 Spain Details
NEXT Oncology Madrid Madrid 28223 Spain Details
Hospital Quironsalud Malaga Málaga 29004 Spain Details
Clinica Universidad de Navarra Pamplona 31008 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field